Coix Seed Oil Exerts an Anti–Triple-Negative Breast Cancer Effect by Disrupting miR-205/S1PR1 Axis

Coix Seed Oil (CSO) possesses a wide range of pharmacological activities. Kanglaite Injection, a commercial product of CSO, has been used clinically as an anticancer drug in China for decades. However, its molecular mechanisms on triple-negative breast cancer (TNBC) remains to be elucidated. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Ting, Jiang, Yi-Xin, Chen, Long, Huang, Ling, Tian, Xin-Hui, Zhou, Yu-Dong, Nagle, Dale G., Zhang, Dan-Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556270/
https://www.ncbi.nlm.nih.gov/pubmed/33101013
http://dx.doi.org/10.3389/fphar.2020.529962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556270/
https://www.ncbi.nlm.nih.gov/pubmed/33101013
http://dx.doi.org/10.3389/fphar.2020.529962

Ejemplares similares